Remarkably, SUCLG2 downregulation completely abolished the increases in KRAS activity, colony formation, and migration mediated by SLC25A21 downregulation in KRAS-mutant CRC cells (Figure 5, C, E, and F, and Supplemental Figure 8A). The gene discussed is SUCLG2; the disease is colorectal carcinoma.